Abstract
In addition to the achievements in technique and technology that off-pump myocardial revascularization presents, minimally invasive coronary artery bypass grafting (MICABG) has subtly made quality of life (QOL) a major concern of cardiac surgeons around the world. Advances in treatment and the subsequent decline in CABG surgery mortality rates over the last 20 yr introduced a need to incorporate these subjective measures in studies evaluating treatment efficacy (1). The most recent elevation of QOL to the forefront of the medical decision-making process stems directly from the unfailing invocation of patient preference as a primary benefit balancing the known risks of MICABG. This may present a renewed opportunity to commit the focus of medicine more closely and consistently toward patient preferences for outcomes.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
